Sight Diagnostics Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
130
- Latest Deal Type
-
2ndary - Private
- Investors
-
13
Sight Diagnostics General Information
Description
Developer of automated microscopy device designed to improve healthcare for everyone through smart blood testing. The company offers a medical platform for diagnosing blood diseases using digital fluorescent microscopy and computer vision algorithms, enabling healthcare providers to perform multiple tests on a single, easy-to-operate platform.
Contact Information
Website
www.sightdx.comCorporate Office
- Derech Menachem Begin 23
- Tel Aviv
- Israel
Corporate Office
- Derech Menachem Begin 23
- Tel Aviv
- Israel
Sight Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Secondary Transaction - Private | 12-Jan-2026 | Completed | Generating Revenue | |||
| 7. Debt - General | 09-Nov-2023 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series D) | 01-Jul-2020 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 14-Feb-2019 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B) | 01-Oct-2017 | Completed | Startup | |||
| 3. Grant | Completed | Startup | ||||
| 2. Early Stage VC (Series A) | 08-Apr-2014 | $6.05M | $9.2M | Completed | Startup | |
| 1. Angel (individual) | 01-Aug-2011 | $3.2M | $3.2M | Completed | Startup |
Sight Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preferred B2 | ||||||||
| Preferred B1 | ||||||||
| Preferred A | 5,000,000 | $1.58 | $1.58 | 1x | $1.58 | 25.79% | ||
| Ordinary | 5,500,000 | $0.85 | $0.85 | 1x | $0.85 | 25.44% |
Sight Diagnostics Comparisons
Industry
Financing
Details
Sight Diagnostics Competitors (8)
One of Sight Diagnostics’s 8 competitors is Genalyte, a Venture Capital-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genalyte | Venture Capital-Backed | San Diego, CA | ||||
| PixCell Medical Technologies | Formerly VC-backed | Yokneam Ilit, Israel | ||||
| Truvian | Venture Capital-Backed | San Diego, CA | ||||
| 1Drop | Formerly VC-backed | Neuchatel, Switzerland | ||||
| Abbott | Corporation | Abbot Park, IL |
Sight Diagnostics Patents
Sight Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025120470-A1 | Varying spatial coherence in a microscope system | Inactive | 04-Dec-2023 | ||
| EP-4713685-A1 | Apparatus and methods for microscopic analysis of a biological sample | Pending | 18-May-2023 | ||
| WO-2024236537-A1 | Apparatus and methods for microscopic analysis of a biological sample | Inactive | 18-May-2023 | ||
| GB-202218615-D0 | System and method for analyzing bodily samples | Inactive | 12-Dec-2022 | ||
| US-20260212494-A1 | System and method for analyzing bodily samples | Pending | 12-Dec-2022 | G06T7/0012 |
Sight Diagnostics Signals
Sight Diagnostics Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BridgeOne Capital | Venture Capital | Minority | ||
| CK Hutchison | Corporation | Minority | ||
| Dancap Family Investment Office | Family Office | Minority | ||
| Koch Disruptive Technologies | Venture Capital | Minority | ||
| ForMED Ventures | Venture Capital | Minority |
Sight Diagnostics FAQs
-
When was Sight Diagnostics founded?
Sight Diagnostics was founded in 2010.
-
Where is Sight Diagnostics headquartered?
Sight Diagnostics is headquartered in Tel Aviv, Israel.
-
What is the size of Sight Diagnostics?
Sight Diagnostics has 130 total employees.
-
What industry is Sight Diagnostics in?
Sight Diagnostics’s primary industry is Diagnostic Equipment.
-
Is Sight Diagnostics a private or public company?
Sight Diagnostics is a Private company.
-
What is Sight Diagnostics’s current revenue?
The current revenue for Sight Diagnostics is .
-
How much funding has Sight Diagnostics raised over time?
Sight Diagnostics has raised $124M.
-
Who are Sight Diagnostics’s investors?
BridgeOne Capital, CK Hutchison, Dancap Family Investment Office, Koch Disruptive Technologies, and ForMED Ventures are 5 of 13 investors who have invested in Sight Diagnostics.
-
Who are Sight Diagnostics’s competitors?
Genalyte, PixCell Medical Technologies, Truvian, 1Drop, and Abbott are some of the 8 competitors of Sight Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process